Second-line fluoropyrimidine-based doublet chemotherapy for advanced biliary tract cancer: a new standard of care?

Expert Rev Gastroenterol Hepatol. 2022 Mar;16(3):201-203. doi: 10.1080/17474124.2022.2047652. Epub 2022 Mar 2.

Authors

Alessandro Rizzo¹, Antonio Cusmai¹, Gennaro Palmiotti¹

Affiliation

¹ Struttura Semplice Dipartimentale di Oncologia Medica per la Presa in Carico Globale del Paziente Oncologico "Don Tonino Bello," I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.

PMID: 35220859
DOI: 10.1080/17474124.2022.2047652

No abstract available

Publication types

Editorial

MeSH terms

Antimetabolites / therapeutic use
Bile Duct Neoplasms*
Biliary Tract Neoplasms* / drug therapy
Humans
Standard of Care

Substances

Antimetabolites